— Know what they know.
Not Investment Advice

NPHC OTC

Nutra Pharma Corp.
1W: +0.0% 1M: +0.0% 3M: -66.7% YTD: -66.7% 1Y: +0.0% 3Y: -66.7% 5Y: -93.3%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $715973 mcap · 7.09B float · 0.0094% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
-$762K +56.3% ▲
Capital Expenditures
$58K -48.5% ▼
5Y CAGR: +44.8%
Free Cash Flow
-$820K +54.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$91K -200.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$4M-$7M-$769K-$13M$8M
Depreciation & Amort.$6K$77K$67K$63K$654K
Stock-Based Comp.$0$72K$8K$154K$20K
Change in Working Capital$453K$406K$304K$73K$927K
Other Non-Cash Items$3M$5M$1M$10M-$11M
Operating Cash Flow-$1000K-$744K-$878K-$2M-$762K
— Investing Activities —
Capital Expenditures$0$0-$6K-$39K-$58K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0-$254K$85K
Investing Cash Flow$0$0-$6K-$294K$27K
— Financing Activities —
Net Debt Issuance$1000K$569K$834K$2M$808K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$175K$50K$0-$164K
Financing Cash Flow$1000K$744K$884K$2M$644K
Net Change in Cash$0$0$0$91K-$91K
Cash End of Period$0$0$0$91K$0
Free Cash Flow-$1000K-$744K-$884K-$2M-$820K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms